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Cardiovascular risk factors in first-degree relatives of
patients with hypertension*
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SUMMARY
Objective: To evaluate the prevalence of cardiovascular risk factors (CRF) and absolute risk (AR) among first-degree
consanguinity relatives of Colombian patients with hypertension.
Methods: The study comprised 227 relatives (siblings and children of both sexes, between 12 and 40 years of age) and 204
hypertensive patients 34-84 years old from Quindío, Colombia. Lipid profile, glycemia, smoking, body mass index, and blood
pressure were analyzed, and the AR of cardiovascular disease (CVD) to 10 years was estimated. Relatives were divided into
two groups: GF1 relatives <18 years, GF2 relatives >18 years.
Results: three or more CRF were found in the three groups. The prevalence for smoking was 20.1%, 9.1%, and 15.9% in
patients, GF1, and GF2, respectively. Hypercholesterolemia was 42.2%, 15.2%, and 18.6% in patients, GF1, and GF2,
respectively. The prevalence of low HDL-c levels was 50.5%, 44.9%, and 63.6% in relatives, GF1, and GF2, respectively.
Obesity was present alone in patients, (32.4%) and GF2 (10.8%). The AR was 19.6 and 6.4 in male and female patients,
respectively; 0.31 and 0 in GF1 females and males, respectively, and in GF2 it was 1.5 and 0.15 in males and females,
respectively.
Conclusions: Patients and relatives had more than three CRFs. HDL-c was low in all three groups. The AR was high in
the young relatives. Programs are needed for weight, smoking, sedentary and dyslipidemia control to prevent or delay the
development of CVD in relatives.
Keysword: Cardiovascular disease; Cardiovascular risk factors; Absolute risk; Hypertension;
Relatives;  Smoking; Hypercholesterolemia.
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RESUMEN
Objetivo: Evaluar la prevalencia de Factores de Riesgo Cardiovascular (FRC), y Riesgo Absoluto (RA) en familiares
consanguíneos de pacientes colombianos hipertensos.
Métodos: Se estudiaron 227 familiares (hermanos e hijos de ambos sexos, entre 12-40 años de edad), y 204 pacientes
hipertensos (34-84 años) del Quindío, Colombia. Los familiares se dividieron en dos: grupo de familiares <18 años (GF1) y
grupo de familiares >18 años (GF2). Se analizaron perfil lipídico, glicemia, tabaquismo e índice de masa corporal y se calculó
el RA de sufrir enfermedad cardiovascular (ECV) a 10 años.
Resultados: Se encontraron tres o más FRC en los tres grupos (pacientes, GF1 y GF2). La prevalencia de tabaquismo fue
20.1% 9.1% y 15.9% en pacientes, GF1 y GF2 respectivamente. La hipercolesterolemia fue 42.2% 15.2% y 18.6% en
pacientes, GF1 y GF2 respectivamente. La prevalencia de niveles bajos de c-HDL fue 50.5%, 44.9% y 63.6% en familiares,
GF1 y GF2, respectivamente. Mientras que la obesidad sólo estuvo presente en los pacientes (32.4%) y en el grupo GF2
(10.8%). El RA fue de 19.6 y 6.4 en los pacientes de género masculino y femenino, respectivamente; de 0.31 y 0 en el GF1
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femenino y masculino, respectivamente; de 1.5 y 0.15 en el
GF2 masculino y femenino, respectivamente.
Conclusiones: Pacientes y familiares tenían más de tres
FRC. El c-HDL fue bajo en los tres grupos. El RA fue alto en
los familiares jóvenes. Se necesitan programas para el con-
trol de peso, tabaquismo, sedentarismo y dislipidemias para
prevenir o retrasar el desarrollo de ECV en los familiares.
Palabras clave: Enfermedades cardiovasculares;
Factores de riesgo cardiovascular; Riesgo absoluto;
Hipertensión; Parientes; Tabaquismo;
Hipercolesterolemia.
Colomb Med. 2011; 42: 17-25
Cardiovascular disease (CVD) causes millions of
deaths per year around the world1. In Colombia, after
violent deaths, CVD occupies the second place, within
the first five causes of mortality in the nation’s general
population2. Hypertension is a risk factor for CVD, in
Colombia close to 24.7% of the adult population suffers
from hypertension3, which contributes to the high
prevalence of CVD in the country.
Evidence from epidemiological studies, clinical
correlations, and genetic studies among others indicate
that high levels of cholesterol, triglycerides, low-density
lipoprotein cholesterol (LDL-c), lipoprotein A,
apolipoprotein B, as well as low levels of high-density
lipoprotein cholesterol (HDL-c), hypertension, obesity,
tobacco smoking, and sedentary life style, among others,
are cardiovascular risk factors (CRF). Identifying and
managing CRFs in patients in populations has permitted
reducing deaths due to CVD in the last 25 years4.
Several studies have been done in Colombia on
CRFs is specific population groups, like individuals
with a first coronary event5, as well as healthy children
and adults from different regions of the country6-8, but
none -according to available literature- includes consan-
guineous relatives of individuals with hypertension
who can have one or more CRF. For this reason, a
family focus is most appropriate in identifying and
preventing the CRFs, given that epidemiological studies
have manifested that around 30% to 50% of the inter-
individual blood pressure variation in the population is
genetically determined3.
Hence, the objective of this work was the analysis of
the CRFs present in young consanguineous relatives of
hypertensive patients to contribute to knowledge on the
disease; thereby, improving the quality of life of
hypertensive patients and their families and helping
healthcare authorities make decisions on prevention
policies in families.
MATERIALS AND METHODS
This was a cross-sectional, descriptive study
conducted from 2007-2009, with a representative sample
of the hypertensive population from health centers,
Healthcare Promotion Companies, and community
centers with hypertension control programs in the
Department of Quindío in Colombia, with 95%
reliability and 5% sampling error.
Study subjects. The study was conducted with
hypertensive Colombian men and women between 34
and 84 years of age, and with their young (between 12
and 40 years of age) Colombian relatives, in first degree
of consanguinity (siblings and offspring), from different
entities like healthcare centers, Healthcare Promotion
Companies, and community centers with hypertension
control programs in the Department of Quindío in
Colombia (we did not explore patient birth place nor
did we include ethnicity markers in the study). All the
healthcare centers in the department were considered.
The selection was established by conglomerates of
healthcare centers and it was conducted via a simple
random sampling. The selection of the participating
hypertensive individuals was done via a systematic
random sampling on the registration lists. The patients
were contacted by telephone or at their healthcare
centers. The study excluded relatives diagnosed with
chronic pulmonary hypertension, previous thyroid
disorders, prior type-I and type-II diabetes, as well as
pregnant women, and those voluntarily leaving the
study. Basic demographic information was obtained
through a survey held at the site where the samples were
taken. This work was approved by the Bioethics
institutional committee in Universidad del Quindío. All
the participants signed an informed consent form; in all
cases, there was strict compliance with the ethical
principles contained in the 1964 Helsinki declaration
and its modifications until 2008 and with Resolution
8430 of 1993 from the Colombian Ministry of Social
Protection. The total simple was of 431 individuals
among hypertensive patients and relatives.
Definition of variables. The study variables were:
19
Colombia Médica                         Vol. 42 Nº 1, 2011 (Enero-Marzo)
Blood pressure, body mass index (BMI), tobacco smo-
king, blood lipids, glycemia, age, and gender;
hypertension was defined as systolic pressure >140
and/or diastolic pressure >90 mmHg, taken from a
seated individual9; overweight was indicated by BMI
between 25 and 29.9 kg/m2, and obesity was established
by BMI >30 kg/m2. Tobacco smoking was taken as the
consumption of at least one cigarette within the last
month10; sedentary life style as the lack of regular
physical activity (>30 minutes, >3 days/week)11, the
type of exercise was not considered nor the intensity of
such, only the duration (time) and frequency (days/
week). Although the survey inquired on the type of diet
[foods ingested within the last two days (breakfast,
lunch, and dinner)], this variable was not controlled.
For lipid profile values, we considered abnormal total
cholesterol (TC) >200 mg/dl, HDL-c <40 mg/dl in men
and <50 mg/dl in women, triglycerides (TAG) >150
mg/dl, and LDL-c >130 mg/dl after fasting for 12 h;
according to the National Cholesterol Education
Program (NCEP)12, hyperglycemia was defined as
fasting glycemia >125 mg/dl13.
Procedures. Blood samples were obtained at the
respective healthcare centers, after 12 h of fasting via
venipuncture in dry tube, the serum was obtained via
centrifuge at 2500 g for 15 minutes at 4°C, separated in
micro-tubes and stored at -20°C until used. Body weight
registered in kilograms with one decimal place was
measured with an electronic scale (0.1-kg precision).
Height was measured with a stadiometer (sensitivity: 1
mm) and it was registered in meters with two decimal
places. Each measurement was taken by previously
standardized personnel and registered twice. BMI in
kg/m2 was calculated with height and weight. Total
cholesterol, TGA, and HDL-c were measured via
commercial enzymatic methods. For those with
triglycerides <400 mg/dl, LDL-c was calculated with
the Friedewald equation14 and VLDL=TGA/5.
Evaluation and stratification of the cardiovascular
risk. Absolute risk (AR) was defined as the probability
of developing coronary or cardiovascular disease during
a given period of time15,16. In this study, AR was
measured at 10 years and it was calculated after knowing
the deduced score of the risk factors; to find the score,
six variables were considered, modifying the score
according to gender, age (years), TC (mg/dl), HDL-c
(mg/dl), glycemia (>126 mg/dl, yes, no), systolic
pressure (>120 mmHg), and smoker (yes, no), using
modified and adapted tables from Grundy et al.15 and
Wilson et al. 16
Statistics. The Kolmogorov Smirnov test was applied
to determine if the variables had a normal distribution.
Confidence intervals at 95% were calculated for
differences of proportions and a Chi-square distribution
was done to see the significance level. This was
established at p<0.05. AR was calculated based on the
sum method of risk factors15,16. Thereafter, we classified
individuals into slight risk (below the AR average for
the population), moderate risk (three times above the
AR average for the population), and high risk (four
times above the AR average for the population). As the
average AR, we took AR of the study subject population.
The data are presented as the mean ± the standard error.
The means of the anthropometric data and the metabolic
characteristics were compared among groups using the
one-way variance analysis (ANOVA). The statistical
analysis was done with the SPSS program version 16.0.
RESULTS
Baseline characteristics of the population. The
study was conducted with 431 subjects; 204 hypertensive
individuals and 227 relatives in first degree of
consanguinity (offspring and siblings between 12 and
40 years of age). Table 1 shows the baseline
characteristics of the population. Of the hypertensive
individuals, 85.7% were women and 14.2% were men.
Because of the broad range of ages of the relatives,
these were distributed into two groups, one with women
and men <18 years of age (GF1) and another group with
women and men >18 years of age (GF2). GF1 repre-
sented 14.5% of the relatives, while GF2 represented
85.5%. The female population had the highest presence
in the three groups studied, representing 70.5%.
Data from Table 1 show that the hypertensive patients
had higher systolic and diastolic pressure than those of
their relatives, even though many of the patients were
medicated (data not shown); hypertensive men presented
higher values of both types of pressure than women in
the group, with significant differences for diastolic
pressure. In GF2, men had higher systolic and diastolic
pressure tan women with significant differences;
however, both pressure figures were within normal
ranges. With respect to BMI, the results indicate that on
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average there is slight overweight condition in patients
(men and women), but not with their relatives.
Lipid profile and glycemia.Table 2 summarizes
results found in these variables. Lipid profile presented
higher levels of TC and LDL-c in the female population
of patients, with significant differences with respect to
male patients; nevertheless, the means for both
parameters were within the normal limits in all the
population groups. VLDL-c was always higher in men
than in women with significant differences for the
patient group and for the GF2 group. Triglycerides
were high in men from the patient group and from the
GF2 group, differences were significant with respect to
women in each group. In both groups of individuals
(male patients and GF2 males), triglycerides were above
the normal range. HDL-c levels in all groups were
below normal parameters. Glycemia was also within
the normal parameters in all the groups, showing
significant differences only between gender in groups
GF1 and GF2.
Prevalence of cardiovascular risk factors different
from hypertension. Table 3 shows that the prevalence
for smoking was presented in the following order:
20.1%, 9.1%, and 15.9% for patients, GF1, and GF2,
respectively, without significant differences among
groups. Hypercholesterolemia (HC) (cholesterol >200
mg/dl) was at 42.2%, 15.2%, and 18.6% for patients,
GF1, and GF2, respectively, with significant differences
between patients and GF1 (p<0.001) and between GF1
and GF2 (p<0.006). The variance analysis for the three
groups revealed significant differences between groups
(<0.001). Sedentary life style was notorious in all the
groups, 31.7% of patients engaged in exercises, while
relatives were engaged in exercise activity by 45.5%
and 25.4% for groups GF1 and GF2, respectively.
Table 1
Baseline characteristics of the study participants
Variable           Patients (n=204)                           GF1 (n=33)                             GF2 (n=194)
               F (n=175) M (n=29)       F (n=17)           M (n=16)         F (n=112)     M (n=82)
Age (years) 58.9±0.7 62.1±2.1 15.7±0.5 15.3±0.6 33.0±0.6 30.7±0.8*
BMI Kg/m2 28.3±0.4 28.1±0.6 20.5±0.6 19.7±0.8 24.6±0.43 24.4±0.4
SP mmHg 129.6±1 134.3±2,9 95.8±2.4 100.3±2.7 105.7±1.1 113.5±1.3*
DP mmHg 71.2±1.1 81.1±2.1* 53.1±1.8 53.6±2.9 59.5±1.1 67.6±1.3
GF1=relatives <18 years  GF2=relatives >18 years  F=female   M= male  BMI= body mass index  SP= systolic pressure
DP= diastolic pressure   * significant differences due to gender among the age groups, p<0.05
Table 2
Lipid profile and glycemia for study participants
Variable                      Patients (n=204)                        GF1 (n=33)                     GF2 (n=194)
                         F (n=175)          M (n=29)    F (n=17)       M (n=16)           F (n=112)     M (n=82)
TC (mg/dl ) 200.3±3.9 179.1±8.3* 157.4±7.8 160.4±10.8 170.9±3.6 175.2±5.0
LDL-c (mg/dl ) 127.2±3.4 104.8±7.7* 95.9±7.1 93.5±8.6 106.0±3.2 101.9±4.4
VLDL-c (mg/dl ) 33.2±1.1 39.0±2.7* 21.8±2.1 30.1±8.8 22.2±1.0 34.8±3.3*
TGA (mg/dl ) 169.9±6.4 197.9±14.7* 109.1±10.3 106.9±13.5 111.3±5.1 182.2±19.8*
HDL-c (mg/dl ) 41.5±0.9 35.3±1.6* 39.7±2.1 42.4±2.8 42.6±0.8 39.0±1.1*
Glycemia (mg/dl) 86.1±1.7 84.8±3.5 75.1±1.7 79.7±2.1* 73.2±0.9 79.5±2.0*
GF1=relatives <18 years  GF2=relatives >18 years  F=female   M= male * significant differences due to gender among
the age groups, p<0.05
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Regarding low levels of HDL-c, the distribution was
50.5%, 44.9%, and 63.6% for patients, GF1, and GF2,
respectively. Significant differences were only found
between patients and GF1 (p<0.001) and between groups
GF1 and GF2 (p<0.01). In the obesity risk factor, there
were no significant differences among the groups, but
Graphic 1 shows a greater percentage of obesity in the
patient group.
Average score per risk factor and percentage of
risk at 10 years. Table 4 shows the average score for
each factor in each of the groups and the percentage of
AR at 10 years in each study group. As expected, male
patients have greater AR (19.6%) of suffering a coronary
event than female patients or the groups of relatives.
Men in GF2 have a higher percentage of risk compared
to men in GF1 and to women in both groups.
Also, data in Table 3 indicate that except for
hypertension and age in patients, the CRFs contributing
most to AR -in patients and relatives- were high TC and
low levels of HDL-c. In the male CF2 group, smoking
habit also contributed to the risk. Glycemia contributed
to the risk only in the patient group. Regarding AR at 10
years, it was almost three times higher for male patients
than for female patients.
Classification of cardiovascular risk factor by
levels. Graphic 1 shows the classification of the
individuals of the study in three risk levels: limit,
medium, and high; revealing greater risk for males in
the patient group and lower risk for females in the GF2
group.
Table 3
Prevalence of risk factors in the study group
Variable  % Patients (n=204) GF1 (n=33) GF2 (n=194)
Smoking 20.1 9.1 15.9
Hypercholesterolemia 52.2 15.21 18.62
HDL-c 50.5 44.9 63.6
Obesity 32.4 0.0 20.8
Sedentary life style 68.3 54.5 47.63
GF1=relatives <18 years  GF2=relatives >18 years    1. Significant differences between patients and GF1.
2. Significant differences between GF1 and GF2. 3. Significant differences among the groups
Table 4
Average value per risk factor and 10-year risk percentage in each study group
Variable                      Patients (n=204)                        GF1 (n=33)                     GF2 (n=194)
                         F (n=175)          M (n=29)    F (n=17)       M (n=16)           F (n=112)     M (n=82)
Age 8.5 8.9 -7 -9 -4.7 -6.5
SP 3.3 1.6 0 0 0.1 0.1
Smoker 0.63 0.9 0.5 1 1 1.6
TC 2.3 1.5 3.1 2.5 2.9 3.3
HDL-c 1.2 1.6 1.5 1.2 1.1 1.3
Glycemia 0.18 0.07 0 0 0 0
Total points 16.11 14.6 -1.9 -4.3 0.4 -0.2
AR % at 10 years 6.4 19.6 0 0.31 0.15 1.5
AR= absolute risk. GF1=relatives <18 years. GF2=relatives >18 years. F= female, M=male. No significant differences were found.
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DISCUSSION
Herein, we describe the prevalence of CRFs and the
absolute risk of suffering cardiovascular disease at 10
years in hypertensive patients and their relatives in first
degree of consanguinity, given that several studies
show that the hereditary part for hypertension varies
between 35% and 65%.10. This agreement of
hypertension in families has been attributed to several
reasons, among them sharing the same exposure to
environmental factors and common genetic components.
Results indicate that the sampling of this study was
constituted in all the groups, mainly by women, which
is habitual in this type of work, in part, due to the low
number of men attending controls for hypertension or
for chronic disease, and in part, because of the labor
difficulties of men or because they worry less about
their health, as has been demonstrated by several studies
on CRF17,18. In this regard, Friedman et al.,18 describe
that there was better correlation between findings of
hypertension in the mother-offspring pair than in the
father-offspring pair. The authors attribute this to the
fact that mothers have
better information of their
family history and better
detection of hypertension
than the fathers.
In this family study,
patients and relatives pre-
sented one or several
CRFs; there was a high
percentage of hypercho-
lesterolemia, low HDL-c,
obesity, and cigarette smo-
king, similar to that found
for unrelated population
groups in Colombia8,17, or
Europe18. Thus, although
mean values of TC in men
and women from the three
groups studied were
within the normal ranges,
when evaluated indivi-
dually, the data showed
that hypercholesterolemia
detected in patients was
































Graphic 1. Classification of absolute risk in the study population
MP= male patient, FP= female patient. GF1M= male relatives <18 years.
GF2M= male relatives >18 years. GF1F= female relatives <18 years.
GF2F= female relatives >18 years
relatives; and although the sample was not represen-
tative when divided into groups, even in the youngest
individuals hypercholesterolemia was above that
described for young healthy populations from other
regions of the country7.
Obesity is a growing problem in Western nations,
including Colombia. It affects adult and young
populations. In our study population we found obesity
in nearly 32% of the hypertensive patients and their
relatives >18 years of age, there is a considerable
prevalence (10.8%), although it is lower than that found
in another study17. This finding points to the risk these
young adults have of suffering CVD, given that some
authors state that being overweight during childhood,
adolescence, or youth increases the risk of suffering
CVD, or other chronic diseases like diabetes, certain
types of cancer, and psychiatric problems19. A sedentary
life style is related to obesity, said life style is considered
an important risk factor for CVD in the general popu-
lation. Research shows that physical activity provides
metabolic and cardiovascular benefits, although the
amount, intensity, and frequency are still under
23
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discussion. In this regard, in the survey done with the
study population, a high percentage of them referred to
practicing physical activity (walking) once and
sometimes twice per week (data not shown), which
placed them as sedentary according to study parameters;
this explains the high percentage of sedentary life styles
found in the study, and suggests that for the population
the relationship is not clear between intensity and
frequency of exercise with the benefits in reducing
cardiovascular risk.
For the tobacco smoking factor, we observed that it
was not only present in the patients, but that it was
present in a high percentage of the young and adult
relatives; although for the young relatives we found
lower rates of tobacco smoking than described in other
Colombian adolescents7,20 it is important to note that
smoking figures weighed considerably when estimating
absolute risk of suffering CVD in this group.
HDL-c levels in serum were very low for all the
groups including the youngest, compared to international
standards12, this finding is repetitive for diverse
population groups studied in the department of
Quindío5,6 and in Colombia7,8, and possibly as shown
by the AR calculation in this work, contributes
significantly to cardiovascular disease.
The presence of three or more CRFs in relatives of
hypertensive patients may possibly be explained based
on the premise that parents, children, and siblings
share, in addition to their genetic susceptibility, the
same family and social realm (diet, habits, income, and
education, among others). Similar findings already
shown in studies like that of Johnson et al.21 which
describes that a small cohort of children with high
blood pressure have parents with a higher-than-expected
prevalence for hypertension, hypercholesterolemia, and
for being overweight; similar to that reported by Reis et
al.,22 who found a correlation between the mean BMI,
waist circumference, blood pressure, and blood levels
of TAG, TC, and HDL-c of parents and offspring;
additionally, these authors also found a strong
association for many of the CRFs between parents and
their children. Regarding the short-term (10 years)
estimation of AR, it is known that this is potentially
useful for identifying individuals who need an aggressive
reduction of the risk factor; in this work for example, we
show that hypertensive patients -in spite of being
medicated (data not shown)- continue displaying slightly
high values of pressure, hypercholesterolemia, very
low levels of HDL-c, and overweight condition; these
findings in the patients could have several inter-
pretations: that the treatment for hypertension and
other CRFs is not suitable, that monitoring of such is
deficient, that patients are careless with their medi-
cations; that there is insufficient education on their own
health, self care and healthy life styles, or a mixture of
these.
Although for some clinicians, in their daily practice,
pressure levels of 130/80 mmHg are taken as slightly
normal and our groups of patients were very close
(women 129/71 mmHg) or slightly above (men 134/81
mmHg), this -together with other risk factors as those
found in patients from the study- predisposes them to
CVD23, particularly if they are not cared for during long
periods; this is indicated by the high figures of absolute
risk found in men (19.6%) and in women (6.4%); values
higher than those described by Jaramillo et al.9 for a
Colombian adult population; the difference between
the two populations is probably due to the presence of
a risk factor (hypertension) as a selection criterion of
the population from the current study.
The AR determination revealed that it is not only
important in monitoring patients, but that its calculation
is quite important for their young relatives; because
albeit in the short-term AR does not appear significant,
in the long term, AR could be unacceptably high due to
its progressive increase with age23. Also, the classi-
fication of risk into three levels: limit, moderate, and
high revealed the same tendency as AR, although most
of the relatives from both groups were within the range
limit, many of them already presented moderate and
even high risk, particularly male relatives.
Our study had important limitations like: the size of
the sample (in spite of it being representative of the
hypertensive population from the healthcare centers),
the group of relatives includes two types offspring and/
or siblings, their age ranges (in adults decisions taken
on life style is less influenced by their hypertensive
relative), the impossibility for controlling their diet
(which could generate bias), not including alcohol
consumption, and not determining ethnic markers. These
limitations did not facilitate the analysis of relationship
or association among factors; however, it is clear that
the data show a high prevalence of some CRFs in the
relatives of these patients.
24
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Hence, early detection of risk in young individuals
like those in our study shows the need for early and
prolonged intervention of the CRFs, even in those with
values of moderate or no risk as revealed by several
studies relating CRF between parents and their
children24.
CONCLUSIONS
Data from the current study indicate that an important
percentage of patients exhibit several CRFs in addition
to hypertension. The CRFs found in hypertensive
patients are also present in their relatives, inclusively in
their younger relatives. The most frequent were
hypercholesterolemia, tobacco smoking, sedentary life
style, and low levels of HDL-c. The population studied,
subject to high and medium risk of suffering
cardiovascular disease at 10 years was over 50%.
These results should motivate health authorities to
implement intervention programs, through medical or
prevention services, in healthcare units for hypertensive
individuals and in entities caring for their relatives.
These programs should tend to diminish the main
cardiovascular risk factors, especially by diminishing
overweight conditions, maintaining tension figures
within adequate ranges, increasing values of HDL-c, as
well as combating cigarette smoking.
Conflict of interest. None of the authors has conflicts
of interest related to this study.
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